News and Comments

ARCA BIOPHARMA: A GENETICALLY TARGETED DRUG FOR ATRIAL FIBRILLATION IN HEART FAILURE PATIENTS

  Thursday, January 09, 2014

A Colorado-based biopharmaceutical company, ARCA Biopharma (ABIO) has a genetically-targeted drug, GencaroTM (bucindolol hydrochloride), for Atrial fibrillation (AF) in patients with heart failure (HF). The drug offers a personalized medicine approach for the treatment of AF in HF, treating only individuals with certain genetic characteristics. This approach enables the selection of individuals who would most probably respond to the drug through excluding the expected non-responders, thus reducing statistically failed trial outcome, in addition to decreasing clinical trial and healthcare costs.    More...


Recent Postings


Archive


Tags

RenenxBio (RGNX) Herceptin Advaxis (ADXS) Bellicum (BLCM) Ocular Therapeutix (OCUL) ARGOS (ARGS) Inovio (INO) Sanofi-Aventis (SAN) Bristol-Myers Squibb (BMY) GUARDIAN HEALTH BIOMARIN (BMRN) Incyte (INCY) Sangamo (SGMO) Trastuzumab-DM1 Anadys (ANDS) Ridaforolimus Micromet (MITI) C4 Therapeutics Exelixis (EXEL) OSI (OSIP) Sarepta (SRPT) Seattle Genetics (SGEN) MODERNA Ariad (ARIA) Alnylam (ALNY) Array Pharmaceuticals (ARRY) TOKAI (TKAOI) Gilead (GILD) Alder Biopharmaceuticals (ALDR) Amgen (AMGN) Aimmune Therapeutics (AIMT) Auspex (ASPX) CompuGen (CGEN) Revlimid (lenolidamide) CEMPRA (CEMP) ADVENTRIX (ANX) Sanofi (SNY) Benlysta (belimumab) Endometrial Cancer galapagos (GLPG) Genentech NANTKWEST (NK) AstraZeneca (AZN) Biocryst (BCRX) CRISPR Therapeutics (CRSP) Merck (MRK) Velcade (bortezomib) Theravance (THRX) HALOZYME (HALO) Sequenom (SQNM) Telaprevir Roche (RHHBY) ISIS (ISIS) Tysabri Zerenex Adaptimmune (ADAP) SYNTA (SNTA) Intercept (ICPT) Onyx (ONXX) Regeneron (REGN) Illumina (ILMN) NEKTAR (NKTR)) VANDA (VNDA) Jazz Pharmaceuticals (JAZZ) Sanofi (SNA) Human Genome Sciences (HGSI) Anacor (ANAC) Theravance Bio Pharma (TBPH) Mirati Therapeutics (MRTX) Biogen Idec (BIIB) Intermune (ITMN) Vitae Pharmaceuticals (VTAE) Abbott Laboratories (ABT) Roche (ROCHE) SERES THERAPEUTICS (MCRB) Agenus (AGEN ABBVIE (ABBV) Global Cell Therapeutics (GBT) Ziofpharm (ZIOP) Cytokinetics (CYTK) GlaxoSmithKline (GSK) Ionis (IONS) Editas (EDIT) INNOVIVA (INVA) Human Longevity (HLI) Xoma (XOMA) Prosensa (RNA) AERIE PHARMACEUTICALS Agenus (AGEN) Dynavax (DVAX) Prolor Biotech (PBTH) ACADIA (ACAD) Intrexon (XON) Vertex (VRTX) KITE (KITE) Valeant Pharmaceuticals International (VRX) ImmunoGen (IMGN) NOVOCURE (NVCR) ZALTRAP™ PTC Therapeutics (PTCT) Rapamune ARCA (ABIO) KERYX (KERX) Idenix (IDIX) Elan (ELN) Multiple Myeloma JUNO (JUNO) REGULUS (RGLS) Dendreon (DNDN) IDERA (IDRA) AGOS (ARGS) SUNESIS PHARMACEUTICALS (SNSS) Galena (GALE) Pluristem (PSTI) Spike Therapeutics (ONCE)